J&J, Distributors Finalize $26 Billion Opioid Settlement
- March 04, 2022
Johnson & Johnson and the nation’s three largest drug distributors--McKesson Corporation, Cardinal Health Inc., and Amerisource Bergen Drug Corporation, said they will forward with a $26 billion nationwide settlement to resolve thousands of claims against them for their alleged roles in fueling the opioid epidemic.
ARTICLE TAGS
You must be logged in to access this content.